表紙
市場調查報告書

神經刺激設備的全球市場 2019年∼2029年:脊髓刺激設備 (SCS),腦深部刺激療設備 (DBS),迷走神經刺激療設備 (VNS),薦椎神經刺激療設備 (SNS),皮質刺激設備 (CS)

Global Neurostimulation Devices Market 2019-2029: Spinal Cord/Deep Brain/Vagus Nerve/Sacral Nerve/Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease

出版商 Visiongain Ltd 商品編碼 224394
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經刺激設備的全球市場 2019年∼2029年:脊髓刺激設備 (SCS),腦深部刺激療設備 (DBS),迷走神經刺激療設備 (VNS),薦椎神經刺激療設備 (SNS),皮質刺激設備 (CS) Global Neurostimulation Devices Market 2019-2029: Spinal Cord/Deep Brain/Vagus Nerve/Sacral Nerve/Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease
出版日期: 2018年11月28日內容資訊: 英文 166 Pages
簡介

全球神經刺激設備市場預計在2024年達到130億美元。並且從2024年到2029年之間,預計將以13%的年複合成長率成長。

本報告提供全球神經刺激設備的市場相關分析,產品的概要和市場基本結構,主要的推動及阻礙市場要素,整體市場趨勢預測,各產品、各用途、各地區的詳細趨勢,主要企業簡介等彙整,為您概述為以下內容。

第1章 調查概要

第2章 神經刺激設備市場簡介

  • 神經刺激設備的分類
  • 所謂神經刺激設備
  • 世界各國的醫療設備的認證、管理體制
    • 美國
    • EU
    • 中國
    • 日本
    • 印度

第3章 神經刺激設備市場:促進、阻礙因素

  • 推動市場要素
    • 神經疾病的患病人數的增加
    • 人口高齡化的加速化
    • 生活習慣的變化和肥胖人口的增加
    • 新興國家市場的多樣的市場機會
  • 阻礙市場要素
    • 能應對持續增加的精神疾病患的神經科醫生不足
    • 醫療制度、政策的變革伴隨的未來不確定性
    • 開發中國家的一次醫療基礎設施的貧乏與醫療保險制度的缺乏

第4章 全球神經刺激設備市場:各產品的預測

  • 脊髓電刺激療設備 (SCS)
  • 腦深部刺激療設備 (DBS)
  • 迷走神經刺激療設備 (VNS)
  • 薦椎神經刺激療設備 (SNS)
  • 皮質刺激設備 (CS)
  • 其他

第5章 全球神經刺激設備市場:各用途的預測

  • 癲癇
  • 疼痛管理
  • 聽力損失
  • 航班、尿失禁
  • 胃輕癱
  • 帕金森氏症
  • 其他的疾病、用途

第6章 全球神經刺激設備市場:各地區的預測

  • 簡介
  • 各地區的市場區隔
  • 各地區市場佔有率的變化預測
  • 北美市場
  • 歐洲市場
  • 亞太地區市場
  • 其他的國家的市場

第7章 神經刺激設備市場代表性企業

  • Advanced Bionics, LLC
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Cyberonics
  • Medtronic plc
  • Neuronetics, Inc.
  • Nevro Corp.
  • Cogentix Medical Inc
  • St. Jude Medical
  • NDI Medical, llc.

第8章 全球神經刺激設備市場:競爭環境

  • 新產品的銷售
  • 企業收購、事業合作/聯盟
  • 其他動向

第9章 結論

  • 神經刺激設備市場:整體未來展望
  • 神經刺激設備市場:各用途的未來展望
  • 神經刺激設備市場:各設備的未來展望

第10章 用語一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0344

The global neurostimulation devices market will reach $13bn in 2024 and is estimated to grow at a CAGR of 13% from 2024 to 2029. In 2018, the spinal cord stimulators segment accounted for 45% of the global neurostimulation devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 102 charts- all unavailable elsewhere.

The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neurostimulation Devices Market from 2019-2029

Forecast of the Global Neurostimulation Devices market by Product:

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Cortical Stimulators
  • Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

Forecast of the Global Neurostimulation Devices market by Application:

  • Pain Management
  • Epilepsy
  • Urinary and Fecal Incontinence
  • Hearing Loss
  • Gastroparesis
  • Parkinson's Disease
  • Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

This report provides individual revenue forecasts to 2028 for these regional and national markets:

  • North America: US, Canada
  • Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
  • Asia-Pacific: Japan, China, India and rest of Asia-Pacific
  • RoW: Latin America, Middle East & Africa

Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:

  • Advanced Bionics
  • Boston Scientific Corporation
  • Cochlear ltd
  • Cyberonics
  • Medtronic
  • Neuronetics Inc
  • Nervo Corp.
  • Cogentic Medical Inc
  • St Jude Medical
  • NDI Medical

Our study discusses the factors that drive and restrain the neurostimulation devices market:

Visiongain's study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.

Buy our report today Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson's Disease’

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Why You Should Read This Report
  • 1.2. How This Report Delivers
  • 1.3. Key Questions Answered by This Analytical Report Include:
  • 1.4. Who is This Report for?
  • 1.5. Methodology
    • 1.5.1. Primary Research
    • 1.5.2. Secondary Research
    • 1.5.3. Market Evaluation & Forecasting Methodology
  • 1.6. Frequently Asked Questions (FAQ)
  • 1.7. Associated Visiongain Reports
  • 1.8. About Visiongain

2. Introduction to the Neurostimulation Devices Market

  • 2.1. Classification of Neurostimulation Devices
  • 2.2. What are Neurostimulation Devices?
  • 2.3. Regulation of Medical Devices?
    • 2.3.1. The US Approval and Regulation System
    • 2.3.2. The EU Approval and Regulation System
    • 2.3.3. China Approval and Regulation System
    • 2.3.4. Japan Approval and Regulation System
    • 2.3.5. India Approval and Regulation System

3. Neurostimulation Devices Market: Drivers & Restraints

  • 3.1. Driving Factors
    • 3.1.1. Growing prevalence of neurological disorders
    • 3.1.2. Increasing Growth of Aging Population
    • 3.1.3. Changing Lifestyle and growing obesity
    • 3.1.4. Various opportunities from emerging markets
  • 3.2. Market Restraints
    • 3.2.1. Shortage of neurologists to treat an increasing number of neurologic patients
    • 3.2.2. Uncertain outcomes of changing healthcare policies
    • 3.2.3. Imposition of the medical device excise tax in the U.S.
    • 3.2.4. Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries

4. Global Neurostimulation Devices Market by Product, 2019-2029

  • 4.1. Spinal Cord Stimulators Market Forecast 2019-2029
  • 4.2. Deep Brain Stimulators Market Forecast 2019-2029
  • 4.3. Vagus Nerve Stimulators Market Forecast 2019-2029
  • 4.4. Sacral Nerve Stimulators: Market Forecast 2019-2029
  • 4.5. Cortical Stimulators Market Forecast 2019-2029
  • 4.6. Other Neurostimulation Devices Market Forecast 2019-2029

5. Global Neurostimulation Devices Market by Application, 2019-2029

  • 5.1. Epilepsy Neurostimulation Devices Market Forecast 2019-2029
  • 5.2. Pain Management Neurostimulation Devices Market Forecast 2019-2029
  • 5.3. Hearing Loss Neurostimulation Devices Market Forecast 2019-2029
  • 5.4. Urinary and Faecal Incontinence Neurostimulation Devices Market Forecast 2019-2029
  • 5.5. Gastroparesis Neurostimulation Devices Market Forecast 2019-2029
  • 5.6. Parkinson's Disease Neurostimulation Devices Market Forecast 2019-2029
  • 5.7. Others Application Market Forecast 2019-2029

6. Global Neurostimulation Devices Market by Region, 2019-2029

  • 6.1. Introduction
  • 6.2. Regional Breakdown of the Global Neurostimulation Devices Market
  • 6.3. How will Regional Market Shares Change to 2029?
  • 6.4. North America Neurostimulation Devices Market 2019-2029
    • 6.4.1. U.S. Neurostimulation Devices Market Forecast 2019-2029
    • 6.4.2. Canada Neurostimulation Devices Market Forecast 2019-2029
  • 6.5. Europe Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.1. Germany Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.2. France Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.3. UK Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.4. Italy Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.5. Spain Neurostimulation Devices Market Forecast 2019-2029
    • 6.5.6. Rest of Europe (RoE)
  • 6.6. Asia-Pacific Neurostimulation Devices Market Forecast 2019-2029
    • 6.6.1. Japan Neurostimulation Devices Market Forecast 2019-2029
    • 6.6.2. China Neurostimulation Devices Market Forecast 2019-2029
    • 6.6.3. India Neurostimulation Devices Market Forecast 2019-2029
    • 6.6.4. Rest of Asia-pacific Neurostimulation Devices Market Forecast 2019-2029
  • 6.7. Rest of the World Neurostimulation Devices Market Forecast 2019-2029
    • 6.7.1. Latin America Neurostimulation Devices Market Forecast 2019-2029
    • 6.7.2. Middle East & Africa Neurostimulation Devices Market Forecast 2019-2029

7. Leading Companies in the Neurostimulation Devices Market

  • 7.1. Advanced Bionics, LLC
    • 7.1.1. Advanced Bionics, LLC: Overview
    • 7.1.2. Advanced Bionics, LLC: Financials
    • 7.1.3. Advanced Biologics, LLC: Product Portfolio
    • 7.1.4. Advanced Biologics, LLC: Developments
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Boston Scientific: Overview
    • 7.2.2. Boston Scientific: Financials
    • 7.2.3. Boston Scientific: Product portfolio
    • 7.2.4. Boston Scientific: Developments
  • 7.3. Cochlear Ltd.
    • 7.3.1. Cochlear Ltd.: Overview
    • 7.3.2. Cochlear Ltd.: Financials
    • 7.3.3. Cochlear Ltd.: Product Portfolio
    • 7.3.4. Cochlear Ltd.: Developments
  • 7.4. Cyberonics
    • 7.4.1. Cyberonics: Overview
    • 7.4.2. Cyberonics: Financials
    • 7.4.3. Cyberonics: Products Portfolio
    • 7.4.4. Cyberonics: Developments
  • 7.5. Medtronic plc
    • 7.5.1. Medtronic plc: Overview
    • 7.5.2. Medtronic plc: Financials
    • 7.5.3. Medtronic plc: Product Portfolio
    • 7.5.4. Medtronic plc: Developments
  • 7.6. Neuronetics, Inc.
    • 7.6.1. Neuronetics, Inc: Overview
    • 7.6.2. Neuronetics, Inc: Financials
    • 7.6.3. Neuronetics, Inc: Product Portfolio
    • 7.6.4. Developments
  • 7.7. Nevro Corp.
    • 7.7.1. Nevro Corp.: Overview
    • 7.7.2. Nevro Corp.: Financials
    • 7.7.3. Nevro Corp.: Product Portfolio
    • 7.7.4. Nevro Corp.: Developments
  • 7.8. Cogentix Medical Inc
    • 7.8.1. Cogentix Medical Inc: Overview
    • 7.8.2. Cogentix Medical Inc: Financials
    • 7.8.3. Cogentix Medical Inc: Product Portfolio
    • 7.8.4. Cogentix Medical Inc: Developments
  • 7.9. St. Jude Medical
    • 7.9.1. St. Jude Medical: Overview
    • 7.9.2. St. Jude Medical: Financials
    • 7.9.3. St. Jude Medical: Product Portfolio
    • 7.9.4. St. Jude Medical: Developments
  • 7.10. NDI Medical, LLC.
    • 7.10.1. NDI Medical, LLC.: Overview
    • 7.10.2. NDI Medical, LLC.: Product portfolio
    • 7.10.3. NDI Medical, LLC.: Developments

8. The Global Neurostimulation Devices Market, Competitive Landscape

  • 8.1. New Product Launches
  • 8.2. Acquisitions, Collaborations, and Partnerships
  • 8.3. Other Developments

9. Conclusions

  • 9.1. Top Neurostimulation Devices Market
  • 9.2. Top Neurostimulation Devices Applications Market
  • 9.3. Top Nations Neurostimulation in the Devices Market
  • Appendices
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 4.1: Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.2: Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.3: Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.4: Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.5: Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.6: Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 4.7: Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.1: Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.2: Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.3: Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.4: Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.5: Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.6: Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.7: Parkinson's Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 5.8: Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.1: Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.2: North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.3: North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.4: North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.5: Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.6: Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.7: Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.8: Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.9: Asia-Pacific Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.10: Asia-Pacific Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.11: Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.12: Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 6.13: Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
  • Table 7.1: Advanced Bionics Product Portfolio
  • Table 7.2: Advanced Bionics: Developments
  • Table 7.3: Boston Scientific Corporation: Product Portfolio
  • Table 7.4: Boston Scientific Corporation: Developments
  • Table 7.5: Cochlear Ltd.: Product Portfolio
  • Table 7.6: Cochlear Ltd.: Developments
  • Table 7.7: Cyberonics.: Product Portfolio
  • Table 7.8: Cyberonics: Developments
  • Table 7.9: Medtronic plc: Product Portfolio
  • Table 7.10: Medtronic plc: Developments
  • Table 7.11: Neuronetics: Product Portfolio
  • Table 7.12: Neuronetics: Developments
  • Table 7.13: Nevro Corp: Product Portfolio
  • Table 7.14: Nevro Corp: Developments
  • Table 7.15: Cogentix Medical: Product Portfolio
  • Table 7.16: Cogentix Medical: Developments
  • Table 7.17: St. Jude Medical: Product Portfolio
  • Table 7.18: St. Jude Medical: Developments
  • Table 7.19: NDI Medical: Product Portfolio
  • Table 7.20: NDI Medical: Developments
  • Table 8.1: New Product Launches
  • Table 8.2: Acquisitions, Collaborations, and Partnerships
  • Table 8.3: Other Developments

List of Figures

  • Figure 2.1: Neurostimulation Devices Market Segmentation
  • Figure 2.2: Stages of regulatory control
  • Figure 3.1: Neurostimulation Devices Market: Drivers and Restraints, 2019-2029
  • Figure 3.2: Share of geriatric population, by region, 2010-2020
  • Figure 4.1: Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 4.2: Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 4.3: Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 4.4: Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 4.5: Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2019-2029
  • Figure 4.6: Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 4.7: Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.1: Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.2: Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.3: Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.4: Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.5: Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.6: Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.7: Parkinson's Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
  • Figure 5.8: Other Neurostimulation Devices Markets by Region: Forecast ($m), 2019-2029
  • Figure 6.1: Neurostimulation Devices Markets by Region: Share (%), 2018
  • Figure 6.2: North America Neurostimulation Devices Markets by Country: Share (%), 2018
  • Figure 6.3: U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.4: Increasing Prevalence Rate in Canada by Chronic Diseases, 2001-2039
  • Figure 6.5: Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.6: Europe Neurostimulation Devices Markets by Country: Share (%), 2018
  • Figure 6.7: Change in population structure in Germany, 1995-2015
  • Figure 6.8: Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.9: France Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.10: U.K. Population estimates and projections, 2010-2039
  • Figure 6.11: U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.12: Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.13: Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.14: Asia-Pacific Neurostimulation Devices Markets by Country (%), 2018
  • Figure 6.15: Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.16: Share of Aging population in total Chinese population, 2011-2016 (%)
  • Figure 6.17: China Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.18: India Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.19: Rest of the World Neurostimulation Devices Markets by Region (%), 2018
  • Figure 6.20: Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 6.21: Middle East and Africa Revenue Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
  • Figure 7.1: Advanced Bionics: Historical Revenues ($m), 2015-2017
  • Figure 7.2: Boston Scientific Corporation: Historical Revenues ($m), 2015-2017
  • Figure 7.3: Cochlear: Historical Revenues ($m), 2015-2017
  • Figure 7.4: Cyberonics: Historical Revenues ($m), 2015-2017
  • Figure 7.5: Medtronic plc: Recent Financials, 2015-2017
  • Figure 7.6: Nevro Corp: Recent Financials, 2015-2017
  • Figure 7.7: Cogentix Medical, Inc.: Recent Financials, 2016-2017
  • Figure 7.8: St. Jude Medical: Recent Financials, 2015-2017
  • Figure 9.1: Top Neurostimulation Devices Market
  • Figure 9.2: Top Neurostimulation Devices Applications
  • Figure 9.3: Top Nations in the Neurostimulation Devices Market

COMPANIES LISTED:

  • Abbott Laboratories
  • Advanced Bionics LLC
  • Alliance BiomedicaPvt Ltd.
  • Axonics Modulation Technologies
  • Blackrock
  • Boston Scientific Corporation
  • Cameron Health
  • Cardiac Pacemakers, Inc.
  • Cochlear AG
  • Cochlear Holdings NV
  • Cochlear Ltd.
  • Cochlear Verwaltungs GmbH
  • Codman & Shurtleff
  • Cogentix Medical Inc.
  • Cyberonics, Inc.
  • ElectroCore
  • Enteromedics
  • EP Technologies
  • Functional Neuromodulation
  • Greatbatch
  • Guidant
  • IntraPace
  • LABORIE Medical Technologies
  • LivaNova
  • Medtronic
  • Microtransponder
  • Morris K. Udall Centers of Excellence for Parkinsons Disease
  • Neuronetics, Inc.
  • Neuropace
  • Neurosigma
  • Nevro
  • Nevro Corp.
  • Otologics
  • Sonova Holding AG
  • St. Jude Medical
  • Stimwave
  • Symetis SA
  • Thoratec
  • Uroplasty Inc.
  • Zynex

List of Organisations:

  • American Academy of Neurology
  • Centers for Disease Control and Prevention (CDC)
  • CFDA
  • Chinese Food & Drug Administration (CFDA)
  • Epilepsy Foundation
  • European Commission
  • Federal Interagency Forum on Aging-Related Statistics
  • Food & Drug Administration (US)
  • Insurance Regulatory and Development Authority (IRDA)
  • International Labour Organization (ILO)
  • Ministry of Health, Labor and Welfare (MHLW)
  • National Health Service (UK)
  • National Institute of Population and Social Security Research
  • National Institutes of Health (NIH)
  • Parkinson's Disease Foundation
  • World Health Organisation (WHO)
Back to Top